After hours: March 18 at 7:59:54 PM EDT Loading Chart for MRNA ...

Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications. Many leading pharma and ...

A few years ago, Moderna (NASDAQ: MRNA) stock soared on the back of the highly successful vaccine it developed in record time. At its peak in 2021, Moderna traded for over $450 per share.

Males with pulmonary arterial hypertension (PAH) have more proinflammatory macrophages — a type of immune cell — in the lungs than do females with the disease, a study suggests. Researchers identified ...

Forbes contributors publish independent expert analyses and insights.

New research could pave the way toward a new method of pulmonary arterial hypertension diagnosis and monitoring. A new type of molecular imaging may help quickly identify the first signs of pulmonary ...

Cereno Scientific says its lead therapeutic candidate, CS1, appears to be able to reverse vascular remodeling associated with pulmonary arterial hypertension (PAH). The findings are based on new data ...

A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Viruses ...